the thing a lot on here get wrong about anteotech future valuation is that they aren't just a company limited with anode and POC technology.
this is how anteotech describes themselves
"At AnteoTech we deliver cutting-edge solutions by creating nanometer thin molecular glues that bind all sorts of materials. Anteo is a pioneer in the relatively new science field: Supramolecular Chemistry."
because of the expertise of the staff and decisions from management, advanced battery technology and life science were the 1st two markets the company have worked on.
look at batteries.
started with anteoX as a binder additive. then worked anteoX into creating Ultranode. then discovered that anteoX reduces the need for CNT's and now we are working with a couple of CNT companies. then we were approached by a separator company and now have been testing with them for about a year.
thats 4 different battery components that are used in many different battery ranges in many different products
in life science
look at the last" in conversation " with Tek and Guatum. the 7 anteobind products can be used with many different life science applications. then look at the papers published over the last decade to show the direction the life science division could be taken.
anteobind NXT is challenging traditional EDC/NHS tech, papers showing anteobind allowing extracellular vesicles tests to work etc, etc
right now anteotech is valued at .8c. what could it be valued at with deals starting to bring in revenue, allowing more staff and testing into many different technologies is an unknown.
actually just having 1 or 2 successful divisions would be a company maker, but with Anteotech's tech it isn't a limiting factor....
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)